Literature DB >> 4261142

Vitamin D intoxication treated with porcine calcitonin.

R M Buckle, T R Gamlen, I M Pullen.   

Abstract

Porcine calcitonin was used to treat three patients with hypercalcaemia due to vitamin D intoxication. In two patients a rapid and sustained fall to normal in serum calcium occurred within three days, in the third patient normocalcaemia was achieved in seven days. In view of its rapid and sustained effect calcitonin may be of value in the urgent treatment of hypercalcaemia due to vitamin D intoxication.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4261142      PMCID： PMC1785685          DOI： 10.1136/bmj.3.5820.205

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  9 in total

1.  Vitamin D intoxication: report of two cases treated with cortisone.

Authors:  J V VERNER; F L ENGEL; H T McPHERSON
Journal:  Ann Intern Med       Date:  1958-04       Impact factor: 25.391

2.  The cause of hypercalcuria in sarcoid and its treatment with cortisone and sodium phytate.

Authors:  F ALBRIGHT; E L CARROLL; E F DEMPSEY; P H HENNEMAN
Journal:  J Clin Invest       Date:  1956-11       Impact factor: 14.808

3.  Effect of cortisone on calcium metabolism in sarcoidosis with hypercalcaemia; possibly antagonistic actions of cortisone and vitamin D.

Authors:  J ANDERSON; C HARPER; C E DENT; G R PHILPOT
Journal:  Lancet       Date:  1954-10-09       Impact factor: 79.321

4.  Nephrotoxic hazard from uncontrolled edathamil calcium-disodium therapy.

Authors:  H FOREMAN; C FINNEGAN; C C LUSHBAUGH
Journal:  J Am Med Assoc       Date:  1956-03-24

5.  Hypercalcaemia and impairment of renal function in generalized sarcoidosis.

Authors:  C E DENT; F V FLYNN; J D NABARRO
Journal:  Br Med J       Date:  1953-10-10

6.  Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia.

Authors:  O L Bijvoet; J van der Sluys Veer; A P Jansen
Journal:  Lancet       Date:  1968-04-27       Impact factor: 79.321

7.  [Existence and activity of thyrocalcitonin in man].

Authors:  G Milhaud; M S Moukhtar; J Bourichon; A M Perault
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1965-11-22

8.  Treatment with thyrocalcitonin of the hypercalcemia of parathyroid carcinoma.

Authors:  C Y Pak; M R Wills; G W Smith; F C Bartter
Journal:  J Clin Endocrinol Metab       Date:  1968-11       Impact factor: 5.958

9.  Effect of thyrocalcitonin in man.

Authors:  G V Foster; G F Joplin; I MacIntyre; K E Melvin; E Slack
Journal:  Lancet       Date:  1966-01-15       Impact factor: 79.321
  9 in total
  5 in total

Review 1.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

Review 2.  Drugs for disorders of bone: pharmacological and clinical considerations.

Authors:  G R Mundy; L G Raisz
Journal:  Drugs       Date:  1974       Impact factor: 9.546

3.  Histological technique for the identification of poisoning in wildlife by the rodenticide calciferol.

Authors:  K A Tarrant; G E Westlake
Journal:  Bull Environ Contam Toxicol       Date:  1984-02       Impact factor: 2.151

4.  A family with massive acute vitamin D intoxication.

Authors:  P F Down; A Polak; R J Regan
Journal:  Postgrad Med J       Date:  1979-12       Impact factor: 2.401

5.  A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis.

Authors:  Danilo C Finamor; Rita Sinigaglia-Coimbra; Luiz C M Neves; Marcia Gutierrez; Jeferson J Silva; Lucas D Torres; Fernanda Surano; Domingos J Neto; Neil F Novo; Yara Juliano; Antonio C Lopes; Cicero Galli Coimbra
Journal:  Dermatoendocrinol       Date:  2013-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.